Trial Profile

Clinical study of LYT-310

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 26 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs LYT-310 (Primary)
Indications Neurological disorders
Focus Adverse reactions

Most Recent Events

20 Dec 2023 According to a PureTech Health media release, initiation of a Phase 1 clinical trial of LYT-310 is expected in the first half of 2024.
05 Dec 2022 New trial record
30 Nov 2022 According to a PureTech Health media release, the company expect to initiate this trial in Q4 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com